stella
beta
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others — Stella
Home
/
Charcot Marie Tooth Disease
/
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
View on ClinicalTrials.gov
Recruiting
Back to Charcot Marie Tooth Disease trials
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Trial locations
(22 sites)
United States
Cedars-Sinai Medical Center, Los Angeles, California
Stanford University, Palo Alto, California
University of Colorado Hospital, Aurora, Colorado
University of Connecticut/Connecticut Children's Medical Center, Hartford, Connecticut
Children's National Hospital, Washington D.C., District of Columbia
University of Miami, Miami, Florida
Nemours Children's Health, Orlando, Florida
Nemours Children's Hospital, Orlando, Florida
University of Iowa, Iowa City, Iowa
Johns Hopkins University, Baltimore, Maryland
Harvard/Massachusetts General Hospital, Boston, Massachusetts
University of Michigan, Ann Arbor, Michigan
University of Minnesota, Minneapolis, Minnesota
University of Rochester, Rochester, New York
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
University of Pennsylvania, Philadelphia, Pennsylvania
St. Jude Children's Research Hospital, Memphis, Tennessee
Seattle Children's Hospital, Seattle, Washington
Australia
University of Westmead, Sydney, New South Wales
Canada
The Hospital for Sick Children, Toronto, Ontario
Italy
C. Besta Neurological Institute, Milan, Milan
United Kingdom
National Hospital of Neurology and Neurosurgery, London, England